Trial record 1 of 1 for:
NCT04391595
LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04391595 |
|
Recruitment Status :
Recruiting
First Posted : May 18, 2020
Last Update Posted : December 31, 2020
|
Sponsor:
Nader Sanai
Collaborators:
Barrow Neurological Institute
Ivy Brain Tumor Center
Eli Lilly and Company
Information provided by (Responsible Party):
Nader Sanai, St. Joseph's Hospital and Medical Center, Phoenix
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2021 |
| Estimated Study Completion Date : | February 2022 |